Clinical Observations
You have full text access to this OnlineOpen article
Hypercalcemia in patients with esophageal carcinoma. The pathophysiologic role of parathyroid hormone-related protein
Article first published online: 28 JUN 2006
DOI: 10.1002/1097-0142(19911215)68:12<2625::AID-CNCR2820681219>3.0.CO;2-T
Copyright © 1991 American Cancer Society
Additional Information
How to Cite
Tachimori, Y., Watanabe, H., Kato, H., Yamaguchi, H., Nagasaki, K., Honda, S., Itabashi, M. and Yamaguchi, K. (1991), Hypercalcemia in patients with esophageal carcinoma. The pathophysiologic role of parathyroid hormone-related protein. Cancer, 68: 2625–2629. doi: 10.1002/1097-0142(19911215)68:12<2625::AID-CNCR2820681219>3.0.CO;2-T
Publication History
- Issue published online: 28 JUN 2006
- Article first published online: 28 JUN 2006
- Manuscript Accepted: 27 MAR 1991
Funded by
- Foundation for Promotion of Cancer Research
References
- 1. Disorders calcium, phosphorus and magnesium metabolism, In: MaxwellMH, KleemanCR, eds. Clinical Disorders of Fluid and Electrolyte Metabolism, ed. 2. New York: McGraw-Hill, 1972; 401–503.
- 2, . Incidence of hypercalcemia and malignant neoplasm. Arch Surg 1980; 115: 704–707.
- 3, , . Hypercalcemia in epidermoid tumors of the head and neck and esophagus. Cancer 1973; 31: 1487–1491.
- 4, , . Hypercalcemia and carcinoma of the esophagus. Ann Intern Med 1974; 80: 415–416.
- 5, , . Hypercalcemia associated with esophageal carcinoma in the absence of bone metastasis. Am J Dig Dis 1975; 20: 173–175.
- 6, . Carcinoma of the esophagus and hypercalcemia. Am J Gastroenterol 1977; 67: 135–140.
- 7. Oesophageal carcinoma and hypercalcemia: A clinical study. Eur J Surg Oncol 1987; 13: 399–403.
- 8World Health Organization. Histological Typing of Gastric and Oesophageal Tumors. Geneva: World Health Organization, 1977; 17–18, 33–36.
- 9World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. Geneva: World Health Organization, 1979; 22–27.
- 10, , et al. A retrospective evaluation of the medical treatment of malignancy-associated hypercalcemia. Gann 1986; 77: 85–91.
- 11, , et al. Detection of gastrin-releasing peptide mRNA in small cell lung carcinomas and medullary thyroid carcinomas using synthetic oligodeoxyribonucleotide probes. Jpn J Clin Oncol 1987; 17: 157–163.
- 12, , et al. Expression of parathyroid hormone-related protein mRNA in tumors obtained from patients with humoral hypercalcemia of malignancy. Gann 1988; 79: 677–681.
- 13, , et al. Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy. Proc Natl Acad Sci USA 1983; 80: 1454–1458.
- 14, , et al. Parathyroid hormone-related protein in tumor tissues obtained from patients with humoral hypercalcemia of malignancy. J Natl Cancer Inst 1990; 82: 40–44.
- 15International Union Against Cancer. TNM Classification of Malignant Tumors, ed. 4. Geneva: International Union Against Cancer, 1987; 40–42.
- 16, . Hypercalcemia of malignancy. Ann Rev Med 1987; 38: 241–256.
- 17, , et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA 1987; 84: 5048–5052.
- 18, , et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: Cloning and expression. Science 1987; 237: 893–896.

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)